IDNA vs. BOUT ETF Comparison
Comparison of iShares Genomics Immunology and Healthcare ETF (IDNA) to Innovator IBD Breakout Opportunities ETF (BOUT)
IDNA
iShares Genomics Immunology and Healthcare ETF
IDNA Description
The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Grade (RS Rating)
Last Trade
$23.30
Average Daily Volume
30,142
34
BOUT
Innovator IBD Breakout Opportunities ETF
BOUT Description
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified. BOUT uses technical analysis to find stocks that are likely to breakout. The funds index relies on an algorithm that establishes a base price (a recent high) for each eligible security. The index then follows the trend for each stock. Selected stocks are ranked by a combination of relative strength and fundamental factors, and then weighted in fixed tiers according to this ranking. In addition, BOUT will move 50% of its portfolio into T-bills based on market signals: a rapid increase in either margin debt or overall stock prices, combined with slowing reversing momentum in the S&P 500. The T-bill position will remain in place until the S&P 500 falls by 50% or show indications of rising momentum. BOUT is rebalanced and reconstituted weekly after the close on Friday. The frequent rebalance schedule means the fund will be highly responsive to the technical factors that drive its strategy, but could also experience high turnover.Grade (RS Rating)
Last Trade
$40.14
Average Daily Volume
2,990
44
Performance
| Period | IDNA | BOUT |
|---|---|---|
| 30 Days | -3.84% | 7.95% |
| 60 Days | -6.24% | 9.94% |
| 90 Days | -6.80% | 9.81% |
| 12 Months | 17.45% | 32.83% |
0 Overlapping Holdings
| Symbol | Grade | Weight in IDNA | Weight in BOUT | Overlap |
|---|
IDNA Overweight 34 Positions Relative to BOUT
| Symbol | Grade | Weight | |
|---|---|---|---|
| EXEL | B | 6.44% | |
| RVMD | C | 5.78% | |
| GILD | C | 5.73% | |
| INCY | C | 5.36% | |
| BGNE | D | 5.04% | |
| ACLX | C | 4.42% | |
| SRPT | F | 3.64% | |
| REGN | F | 3.22% | |
| MRK | D | 2.97% | |
| TWST | F | 2.77% | |
| SWTX | C | 2.39% | |
| IOVA | F | 2.38% | |
| BEAM | D | 2.36% | |
| LGND | C | 2.33% | |
| GERN | D | 2.18% | |
| DVAX | C | 1.93% | |
| BCRX | D | 1.7% | |
| NRIX | C | 1.69% | |
| BPMC | B | 1.46% | |
| NVAX | F | 1.24% | |
| MRNA | F | 1.13% | |
| CRSP | D | 1.01% | |
| VIR | D | 0.9% | |
| RCUS | F | 0.88% | |
| IBRX | C | 0.84% | |
| ARCT | F | 0.53% | |
| OABI | F | 0.47% | |
| NTLA | F | 0.39% | |
| FDMT | F | 0.38% | |
| XNCR | B | 0.35% | |
| QURE | C | 0.35% | |
| DNA | F | 0.32% | |
| EDIT | F | 0.28% | |
| MGNX | F | 0.26% |
IDNA Underweight 44 Positions Relative to BOUT
| Symbol | Grade | Weight | |
|---|---|---|---|
| PACS | F | -4.48% | |
| MS | A | -4.47% | |
| LBRDK | C | -4.44% | |
| NEM | D | -4.42% | |
| VIK | B | -4.39% | |
| EXPE | B | -4.28% | |
| EQIX | A | -4.25% | |
| AHR | A | -4.24% | |
| IDCC | B | -4.01% | |
| ETN | A | -3.82% | |
| SPGI | C | -3.81% | |
| EQH | C | -3.78% | |
| CRM | B | -3.73% | |
| BAH | F | -3.73% | |
| DVA | C | -3.71% | |
| PGR | A | -3.63% | |
| CRDO | B | -2.87% | |
| VRNS | D | -2.61% | |
| ULS | B | -2.59% | |
| IR | B | -2.49% | |
| DT | D | -2.49% | |
| NMIH | C | -2.44% | |
| ONON | A | -2.35% | |
| COLL | F | -2.23% | |
| TSM | B | -1.31% | |
| TBBK | B | -1.28% | |
| NOW | A | -1.27% | |
| CDNA | D | -1.24% | |
| SCCO | F | -1.22% | |
| SN | D | -1.2% | |
| TCOM | B | -1.14% | |
| BEKE | D | -1.06% | |
| ROAD | B | -0.45% | |
| AXON | A | -0.43% | |
| TPH | D | -0.42% | |
| IBKR | A | -0.42% | |
| CWAN | B | -0.42% | |
| AVGO | D | -0.42% | |
| ALKT | B | -0.42% | |
| GMED | A | -0.41% | |
| CORT | B | -0.41% | |
| ACGL | C | -0.4% | |
| PLMR | A | -0.39% | |
| JD | D | -0.38% |
IDNA: Top Represented Industries & Keywords
BOUT: Top Represented Industries & Keywords
Compare ETFs
